
Top Five Prostate Cancer Imaging Content in 2025
Catch up on the most well-viewed prostate cancer imaging content from 2025.
We take a look back at the most well-viewed prostate cancer (PCa) imaging content from 2025 with topics ranging from the prognostic value of baseline PSMA PET/CT in patients with metastatic castration-resistant prostate cancer (mCRPC) and the potential of abbreviated MRI for imaging of clinically significant prostate cancer (csPCa) to a meta-analysis examining the use of PSMA PET for detecting PCa recurrence and metastasis. Review the slideshow below to see highlighted PCa imaging content from the past year.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.




























